• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Leu-M 1 immunoreactivity in papillary carcinomas of the thyroid gland; microcarcinoma, encapsulated, conventional and diffuse sclerosing subtypes.

作者信息

Alejo M, Peiro G, Oliva E, Matias-Guiu X

出版信息

Virchows Arch A Pathol Anat Histopathol. 1991;419(5):447-8. doi: 10.1007/BF01605080.

DOI:10.1007/BF01605080
PMID:1750190
Abstract
摘要

相似文献

1
Leu-M 1 immunoreactivity in papillary carcinomas of the thyroid gland; microcarcinoma, encapsulated, conventional and diffuse sclerosing subtypes.甲状腺乳头状癌中的Leu-M 1免疫反应性；微癌、包膜型、经典型和弥漫硬化型亚型。
Virchows Arch A Pathol Anat Histopathol. 1991;419(5):447-8. doi: 10.1007/BF01605080.
2
[The importance of S-100 protein positive Langerhans cells and Leu-M1 positive tumor cells for prognosis of papillary thyroid cancer].[S-100蛋白阳性朗格汉斯细胞和Leu-M1阳性肿瘤细胞对甲状腺乳头状癌预后的重要性]
Zentralbl Chir. 1992;117(11):603-6.
3
Intercellular adhesion molecule-1 (ICAM-1) immunoreactivity in well-differentiated thyroid papillary carcinomas.高分化甲状腺乳头状癌中细胞间黏附分子-1（ICAM-1）的免疫反应性
Mod Pathol. 1996 Jan;9(1):53-6.
4
Distribution of Leu-7 antigen (HNK-1) in thyroid tumors: its usefulness as a diagnostic marker for follicular and papillary carcinomas.亮氨酸-7抗原（HNK-1）在甲状腺肿瘤中的分布：其作为滤泡状癌和乳头状癌诊断标志物的用途。
Hum Pathol. 1992 Jan;23(1):21-5. doi: 10.1016/0046-8177(92)90005-n.
5
[Immunohistology and prognosis in thyroid cancer. Determination of the malignancy potential of papillary and medullary neoplasms by the detection of S-100 protein and Leu-M1 antigen].甲状腺癌的免疫组织学与预后。通过检测S-100蛋白和Leu-M1抗原确定乳头状和髓样肿瘤的恶性潜能
Acta Med Austriaca. 1989;16(1):2-5.
6
Medullary carcinoma of the thyroid.甲状腺髓样癌
Recent Results Cancer Res. 1990;118:41-7. doi: 10.1007/978-3-642-83816-3_5.
7
Aberrant expression of HLA-DR antigen in diffuse sclerosing variant of papillary carcinoma of thyroid.甲状腺乳头状癌弥漫性硬化型中HLA - DR抗原的异常表达。
J Clin Pathol. 1989 Dec;42(12):1309. doi: 10.1136/jcp.42.12.1309-a.
8
Prognostic significance of Leu-M1 immunostaining in papillary carcinomas of the thyroid gland.Leu-M1免疫染色在甲状腺乳头状癌中的预后意义
Virchows Arch A Pathol Anat Histopathol. 1987;411(5):435-9. doi: 10.1007/BF00735224.
9
Immune response to papillary thyroid carcinoma.对甲状腺乳头状癌的免疫反应。
J Clin Endocrinol Metab. 1996 Nov;81(11):4175-6. doi: 10.1210/jcem.81.11.8923882.
10
Papillary carcinoma of thyroid: classical and variants.甲状腺乳头状癌：经典型及变异型
Histol Histopathol. 1990 Apr;5(2):241-57.

引用本文的文献

1
Multiple brain metastases from a diffuse sclerosing variant of papillary carcinoma of the thyroid.甲状腺乳头状癌弥漫性硬化变异型的多发脑转移。
Endocr Pathol. 2000 Spring;11(1):97-108. doi: 10.1385/ep:11:1:97.

本文引用的文献

1
Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinomas. Immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data.甲状腺乳头状癌患者的树突状/朗格汉斯细胞与预后。106例甲状腺肿瘤的免疫细胞化学研究及其与随访数据的相关性。
Am J Clin Pathol. 1988 Mar;89(3):295-300. doi: 10.1093/ajcp/89.3.295.
2
Prognostic significance of Leu-M1 immunostaining in papillary carcinomas of the thyroid gland.Leu-M1免疫染色在甲状腺乳头状癌中的预后意义
Virchows Arch A Pathol Anat Histopathol. 1987;411(5):435-9. doi: 10.1007/BF00735224.
3
Diffuse sclerosing variant of papillary thyroid carcinoma. A clinicopathologic study of 10 cases.
Pathol Res Pract. 1989 Aug;185(2):200-6. doi: 10.1016/S0344-0338(89)80252-3.
4
Diffuse sclerosing variant of papillary thyroid carcinoma. Clinicopathologic study of 15 cases.甲状腺乳头状癌弥漫性硬化型。15例临床病理研究。
Am J Surg Pathol. 1989 Dec;13(12):1041-9. doi: 10.1097/00000478-198912000-00006.
5
Diffuse sclerosing variant of papillary carcinoma of the thyroid: a histological and immunohistochemical study of three cases.甲状腺乳头状癌的弥漫性硬化变体：三例病例的组织学和免疫组织化学研究
Histopathology. 1987 Feb;11(2):191-201. doi: 10.1111/j.1365-2559.1987.tb02622.x.
6
Diffuse sclerosing variant of papillary carcinoma of the thyroid. Clinical importance, surgical treatment, and follow-up study.甲状腺乳头状癌的弥漫性硬化变体。临床重要性、手术治疗及随访研究。
Cancer. 1990 Dec 1;66(11):2306-12. doi: 10.1002/1097-0142(19901201)66:11<2306::aid-cncr2820661109>3.0.co;2-p.
7
Diffuse sclerosing variant of papillary carcinoma of the thyroid. A histopathological study of four cases.甲状腺乳头状癌的弥漫性硬化变异型。4例组织病理学研究。
Acta Pathol Jpn. 1990 Mar;40(3):193-8. doi: 10.1111/j.1440-1827.1990.tb03322.x.
8
Diffuse sclerosing variant of papillary thyroid carcinoma. S-100 protein immunocytochemistry and prognosis.甲状腺乳头状癌的弥漫性硬化变异型。S-100蛋白免疫细胞化学与预后。
Virchows Arch A Pathol Anat Histopathol. 1990;416(4):367-71. doi: 10.1007/BF01605298.
9
Diffuse sclerosing variant of papillary thyroid carcinoma.甲状腺乳头状癌弥漫性硬化变异型
Am J Surg Pathol. 1991 May;15(5):492-3.
10
Diffuse sclerosing variant of papillary carcinoma of the thyroid. Report of three cases.
Acta Pathol Jpn. 1990 Sep;40(9):676-82. doi: 10.1111/j.1440-1827.1990.tb01615.x.